Important Announcements

Nondiscrimination Statement Update

Boston Medical Center Health System complies with applicable Federal civil rights laws and does not discriminate on the basis of age, race, color, national origin (including limited English proficiency and primary language), religion, culture, physical or mental disabilities, socioeconomic status, sex, sexual orientation and gender identity and/or expression. BMCHS provides free aids and services to people with disabilities and free language services to people whose primary language is not English.

To see our full nondiscrimination statement, click here.

Campus Construction Update

Starting September 14, we’re closing the Menino building lobby entrance. This, along with the ongoing Yawkey building entrance closure, will help us bring you an even better campus experience that matches the exceptional care you've come to expect. Please enter the Menino and Yawkey buildings through the Moakley building, and make sure to leave extra time to get to your appointment. Thank you for your patience. 

Click here to learn more about our campus redesign. 

Sobre

Elizabeth S. Klings, MD, is a pulmonologist, Director of the Center for Excellence in Sickle Cell Disease (the largest sickle cell center in New England), and Director of the Pulmonary Hypertension Center at Boston Medical Center. She specializes in caring for patients with chronic dyspnea, pulmonary hypertension, pulmonary embolism, and pulmonary complications from sickle cell disease. She is also an associate professor of medicine at Boston University Chobanian & Avedisian School of Medicine. At BMC, she practices in the Pulmonary Hypertension Clinic, in the Medical Intensive Care Unit, and on the Pulmonary Consultation Service. Dr. Klings’ research is focused on pulmonary vascular complications from sickle cell disease, using genomic and proteomic tools to explore underlying biological mechanisms, and is also studying how sleep-disordered breathing and venous thromboembolism contribute to dysfunction in these patients. She is an internationally recognized leader in treating patients with sickle cell disease and pulmonary hypertension, and in 2014 led the committee that developed new clinical guidelines for the American Thoracic Society.
  • Departments

  • Specialties

    Pulmonary hypertension, pulmonary complications of sickle cell disease, pulmonary embolism, chronic dyspnea

  • Contato

    617.638.7480
  • Primary Location

    725 Albany Street
    9th Floor, Suite 9B
    Boston, MA 02118
  • Administrative Title

    Director of the Center for Excellence in Sickle Cell Disease, Director of Pulmonary Hypertension, and Professor of Medicine, Boston University Chobanian and Avedisian School of Medicine

  • Residency

    Internal Medicine, Boston University Medical Center, 1992-1995
  • Fellowship

    Pulmonary Disease and Critical Care Medicine, Boston University Medical Center, 1995-2000
  • Education

    New York University School of Medicine, 1992
  • Board Certifications

    Internal Medicine, Critical Care Medicine and Pulmonary Disease, American Board of Internal Medicine